methylguanidine has been researched along with Diabetic Glomerulosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fukunaga, Y; Ienaga, K; Kanatsuna, T; Nakamura, K; Nakano, K | 1 |
| Hasegawa, G; Ienaga, K; Kanatsuna, T; Kondo, M; Mori, H; Nakai, M; Nakamura, K; Nakamura, Y; Nakano, K; Sawada, M | 1 |
1 trial(s) available for methylguanidine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Diabetic renal failure and serum accumulation of the creatinine oxidative metabolites creatol and methylguanidine.
Topics: Creatinine; Diabetic Nephropathies; Female; Humans; Kidney Failure, Chronic; Male; Methylguanidine; Middle Aged; Oxidation-Reduction; Oxidative Stress | 1996 |
1 other study(ies) available for methylguanidine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Creatol and chronic renal failure.
Topics: Biomarkers; Creatinine; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Methylguanidine; Oxidative Stress | 1994 |